Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.53B |
| 2 |
NVIDIA
NVDA
|
+$1.07B |
| 3 |
Capital One
COF
|
+$1.02B |
| 4 |
Apple
AAPL
|
+$998M |
| 5 |
Amazon
AMZN
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$671M |
| 3 |
Coca-Cola
KO
|
+$501M |
| 4 |
Qualcomm
QCOM
|
+$435M |
| 5 |
Applovin
APP
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.45% |
| 2 | Financials | 14.05% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.36% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Cartesian Therapeutics
RNAC
$263M
| $2.28M | ﹤0.01% |
218,927
-6,573
| -3% | -$70K |
|
3102
Protara Therapeutics
TARA
$232M
| $2.26M | ﹤0.01% |
744,519
+397,822
| +115% | +$1.37M |
|
3103
Finward Bancorp
FNWD
$196M
| $2.26M | ﹤0.01% |
81,669
+40,778
| +100% | +$1.2M |
|
3104
Pro-Dex
PDEX
$215M
| $2.26M | ﹤0.01% |
51,668
+24,927
| +93% | +$1.22M |
|
3105
Lexicon Pharmaceuticals
LXRX
$1.04B
| $2.25M | ﹤0.01% |
2,377,694
-1,311,577
| -36% | -$850K |
|
3106
CVRx
CVRX
$78.1M
| $2.25M | ﹤0.01% |
382,437
+23,079
| +6% | +$159K |
|
|
SLDE
3107
Slide Insurance Holdings
SLDE
$2.52B
| $2.24M | ﹤0.01% |
+103,643
| New | +$2.23M |
|
3108
SunPower Inc
SPWR
$48.8M
| $2.22M | ﹤0.01% |
1,208,997
+753,168
| +165% | +$1.3M |
|
3109
Bilibili
BILI
$7.14B
| $2.22M | ﹤0.01% |
103,666
+713
| +0.7% | +$13.1K |
|
3110
Lineage Cell Therapeutics
LCTX
$266M
| $2.21M | ﹤0.01% |
2,431,619
-2,053,967
| -46% | -$1.22M |
|
3111
Sanara MedTech
SMTI
$314M
| $2.21M | ﹤0.01% |
77,739
-11,014
| -12% | -$330K |
|
3112
TMC The Metals Company
TMC
$1.91B
| $2.18M | ﹤0.01% |
330,823
+146,650
| +80% | +$562K |
|
3113
Stoneridge
SRI
$202M
| $2.18M | ﹤0.01% |
308,978
-329,654
| -52% | -$1.61M |
|
|
NGD
3114
DELISTED
New Gold Inc
NGD
| $2.17M | ﹤0.01% |
433,971
+13,544
| +3% | +$55.7K |
|
|
INGM
3115
Ingram Micro Holding
INGM
$6.53B
| $2.15M | ﹤0.01% |
103,184
+10,878
| +12% | +$203K |
|
|
CAN
3116
Canaan Creative
CAN
$159M
| $2.13M | ﹤0.01% |
3,452,553
+1,409,812
| +69% | +$991K |
|
3117
Nuvectis Pharma
NVCT
$627M
| $2.13M | ﹤0.01% |
285,332
+149,999
| +111% | +$1.36M |
|
3118
Ericsson
ERIC
$33.7B
| $2.12M | ﹤0.01% |
250,389
+1,658
| +0.7% | +$13.6K |
|
|
MPX
3119
DELISTED
Marine Products Corp
MPX
| $2.11M | ﹤0.01% |
248,087
+2,464
| +1% | +$20.6K |
|
3120
NI Holdings
NODK
$313M
| $2.11M | ﹤0.01% |
165,710
-7,763
| -4% | -$100K |
|
3121
Star Bulk Carriers
SBLK
$3.21B
| $2.11M | ﹤0.01% |
122,115
+2,748
| +2% | +$42.7K |
|
3122
Alvotech
ALVO
$1.38B
| $2.1M | ﹤0.01% |
230,291
+1,574
| +0.7% | +$14.8K |
|
3123
GrafTech
EAF
$204M
| $2.09M | ﹤0.01% |
215,092
-294,892
| -58% | -$2.61M |
|
3124
Consumer Portfolio Services
CPSS
$207M
| $2.09M | ﹤0.01% |
212,555
+16,563
| +8% | +$152K |
|
3125
Inhibikase Therapeutics
IKT
$380M
| $2.08M | ﹤0.01% |
1,066,700
+741,940
| +228% | +$1.45M |
|
Similar funds
Geode Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Geode Capital Management held 4,594 positions worth $1.43T, up 12% from $1.27T the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Geode Capital Management's Q2 2025 filing shows 119 new, 2,787 increased, 1,425 reduced and 150 closed positions. Its largest new stake was Emera Inc: 3,219,448 shares worth $152M. The largest sale was Discover Financial Services, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q2 2025 buy was Emera Inc: 3,219,448 shares worth $152M.
- Geode Capital Management added most to Microsoft in Q2 2025, an estimated $1.53B increase.
- Geode Capital Management's biggest Q2 2025 reduction was Palantir, cutting an estimated $671M.
- Geode Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $1.09B.
- Geode Capital Management's ten largest holdings make up 32% of its $1.43T portfolio in Q2 2025.
- Geode Capital Management opened 119 new positions and closed 150 in Q2 2025.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $1.43T.
Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.